Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06364748 · ClinicalTrials.gov registry record · NA
Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
A NA study, sponsored by West Michigan Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06364748 is a NA study that has completed, run by West Michigan Cancer Center. The registered enrollment target is 20 participants.
The verdict
NCT06364748, a NA study, has completed, sponsored by West Michigan Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient satisfaction.
Interventions
- DEVICE Cellular enabled blood pressure cuff
- DEVICE Standard of Care Cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2025-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06364748
The ClinicalTrials.gov registry entry for NCT06364748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Michigan Cancer Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cellular enabled blood pressure cuff is the first listed.
NCT06364748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06364748 about?
NCT06364748 is a clinical study titled "Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer". A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient sa...
What is the current status of trial NCT06364748?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-11. Estimated completion is 2025-09-26.
What interventions are being tested in trial NCT06364748?
The interventions under investigation include: Cellular enabled blood pressure cuff (DEVICE), Standard of Care Cuff (DEVICE).
Who is sponsoring clinical trial NCT06364748?
This trial is sponsored by West Michigan Cancer Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.